TRANSANAL TOTAL MESORECTAL EXCISION (TaTME) FOR LOW RECTAL CANCER – OUR EXPERIENCE.
EAES Academy. Georgopoulos N. 07/05/22; 363011; P054
Nikolaos Georgopoulos
Contributions
Contributions
Abstract
Aim:
The transanal total mesorectal excision (TaTME) is a valuable and relatively new technique for low rectal cancer surgery. It consists of a conjoined standard laparoscopic low anterior resection and the transanal endoscopic approach. In this poster we describe our first five TaTMEs of our surgical department with emphasis in the surgical technique and postoperative and oncological outcomes.
Methods:
Five patients (2 males and 3 females) with average age 47,8 years (24 to 60) underwent laparoscopic TaTME due to very low rectal cancer in four patients and due to familial polyposis in one. All patients underwent MRI for staging. All cancer patients received neo-adjuvant chemoradiotherapy with substaging of the original disease. Surgical technique, postoperative complications and oncological outcomes are decribed.
Results:
Average operative time was 313 minutes (285 to 360 minutes). There was a vaginal rupture intraoperatively which was sutured laparoscopically. Postoperatively a patient suffered from left ureter stenosis which was successfully managed with a pigtail catheter. Average hospital stay was 6,2 days (5-7). Postoperative follow up included digital rectal exam, orthoscopy and abdominal CT every 6 months and colonoscopy yearly. No recurrence was observed during follow up (1-3 years).
Conclusion:
TaTME in experienced hands and specialized training is a feasible and safe alternative for the management of very low rectal cancer offering sphincter conservation, low complication rates and satisfactory oncologic outcome.
The transanal total mesorectal excision (TaTME) is a valuable and relatively new technique for low rectal cancer surgery. It consists of a conjoined standard laparoscopic low anterior resection and the transanal endoscopic approach. In this poster we describe our first five TaTMEs of our surgical department with emphasis in the surgical technique and postoperative and oncological outcomes.
Methods:
Five patients (2 males and 3 females) with average age 47,8 years (24 to 60) underwent laparoscopic TaTME due to very low rectal cancer in four patients and due to familial polyposis in one. All patients underwent MRI for staging. All cancer patients received neo-adjuvant chemoradiotherapy with substaging of the original disease. Surgical technique, postoperative complications and oncological outcomes are decribed.
Results:
Average operative time was 313 minutes (285 to 360 minutes). There was a vaginal rupture intraoperatively which was sutured laparoscopically. Postoperatively a patient suffered from left ureter stenosis which was successfully managed with a pigtail catheter. Average hospital stay was 6,2 days (5-7). Postoperative follow up included digital rectal exam, orthoscopy and abdominal CT every 6 months and colonoscopy yearly. No recurrence was observed during follow up (1-3 years).
Conclusion:
TaTME in experienced hands and specialized training is a feasible and safe alternative for the management of very low rectal cancer offering sphincter conservation, low complication rates and satisfactory oncologic outcome.
Aim:
The transanal total mesorectal excision (TaTME) is a valuable and relatively new technique for low rectal cancer surgery. It consists of a conjoined standard laparoscopic low anterior resection and the transanal endoscopic approach. In this poster we describe our first five TaTMEs of our surgical department with emphasis in the surgical technique and postoperative and oncological outcomes.
Methods:
Five patients (2 males and 3 females) with average age 47,8 years (24 to 60) underwent laparoscopic TaTME due to very low rectal cancer in four patients and due to familial polyposis in one. All patients underwent MRI for staging. All cancer patients received neo-adjuvant chemoradiotherapy with substaging of the original disease. Surgical technique, postoperative complications and oncological outcomes are decribed.
Results:
Average operative time was 313 minutes (285 to 360 minutes). There was a vaginal rupture intraoperatively which was sutured laparoscopically. Postoperatively a patient suffered from left ureter stenosis which was successfully managed with a pigtail catheter. Average hospital stay was 6,2 days (5-7). Postoperative follow up included digital rectal exam, orthoscopy and abdominal CT every 6 months and colonoscopy yearly. No recurrence was observed during follow up (1-3 years).
Conclusion:
TaTME in experienced hands and specialized training is a feasible and safe alternative for the management of very low rectal cancer offering sphincter conservation, low complication rates and satisfactory oncologic outcome.
The transanal total mesorectal excision (TaTME) is a valuable and relatively new technique for low rectal cancer surgery. It consists of a conjoined standard laparoscopic low anterior resection and the transanal endoscopic approach. In this poster we describe our first five TaTMEs of our surgical department with emphasis in the surgical technique and postoperative and oncological outcomes.
Methods:
Five patients (2 males and 3 females) with average age 47,8 years (24 to 60) underwent laparoscopic TaTME due to very low rectal cancer in four patients and due to familial polyposis in one. All patients underwent MRI for staging. All cancer patients received neo-adjuvant chemoradiotherapy with substaging of the original disease. Surgical technique, postoperative complications and oncological outcomes are decribed.
Results:
Average operative time was 313 minutes (285 to 360 minutes). There was a vaginal rupture intraoperatively which was sutured laparoscopically. Postoperatively a patient suffered from left ureter stenosis which was successfully managed with a pigtail catheter. Average hospital stay was 6,2 days (5-7). Postoperative follow up included digital rectal exam, orthoscopy and abdominal CT every 6 months and colonoscopy yearly. No recurrence was observed during follow up (1-3 years).
Conclusion:
TaTME in experienced hands and specialized training is a feasible and safe alternative for the management of very low rectal cancer offering sphincter conservation, low complication rates and satisfactory oncologic outcome.
{{ help_message }}
{{filter}}